Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.25.0.1
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2024
Accounting Policies [Abstract]  
Schedule of Intangible Assets

  

Website   $ 1,516  
Less website amortization     (348 )
Customer list     664,237  
Intangible Assets     664,237  
Less Customer list amortization     (152,220 )
Amortization     (152,220 )
Net Intangible Assets   $ 513,185  
Schedule of Expected Amortization Expense of Intangible Assets

Expected amortization expense of intangible assets over the next 2 years is as follows:

 

Twelve Months ended June 30,

 

         
2024   $ 249,656  
2025     263,529  
Net Intangible Assets   $ 513,185  
Schedule of Disaggregation of Revenue

In the following table, revenue is disaggregated by primary geographical market, major product line, and timing of revenue recognition.

Schedule of Disaggregation of Revenue  

In thousands of US dollars ($)   Three Months Ended
June 30,
    Six Months Ended
June 30,
 
Primary geographical markets   2024     2023     2024     2023  
North America   $ 409     $ 261     $ 749     $ 816  
Europe     2       18       8       54  
Asia     11       233       14       382  
    $ 422     $ 512     $ 771     $ 1,252  

 

    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
Major products/services lines   2024     2023     2024     2023  
Hardware   $ 105     $ 293     $ 188     $ 721  
Consumables     22       57       60       123  
Contract research services     7       31       7       36  
Sample preparation accessories     16       37       64       82  
Consumer Products     259       -       413       -    
Technical support/extended service contracts     11       46       31       89  
Agrochem Products     -       35       -       166  
Shipping and handling     2       8       8       27  
Other     -       5       -       8  
    $ 422     $ 512     $ 771     $ 1,252  

 

    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
Timing of revenue recognition   2024     2023     2024     2023  
Products transferred at a point in time   $ 404     $ 435     $ 732     $ 1,127  
Services transferred over time     18       77       39       125  
    $ 422     $ 512     $ 771     $ 1,252  
Schedule of Contract Balances

Contract balances

  

In thousands of US dollars ($)   June 30, 2024     December 31, 2023  
Receivables, which are included in ‘Accounts Receivable’   $ 184     $ 151  
Contract liabilities (deferred revenue)     243       34  
Schedule of Future Related to Performance Obligations

The following table includes estimated revenue expected to be recognized in the future related to performance obligations that are unsatisfied (or partially unsatisfied) at the end of the reporting period.

  

In thousands of US dollars ($)   2024     2025     Total  
Extended warranty service   $ 230     $ 13     $ 243  
Schedule of Customer Concentration Risk Percentage

The following table illustrates the level of concentration as a percentage of total revenues during the three and six months ended June 30, 2024 and 2023.

  

    Three Months Ended
June 30,
    Six Months Ended
June 30,
 
    2024     2023     2024     2023  
Top five customers     35 %     70 %     34 %     55 %
Federal agencies     1 %     1 %     1 %     1 %

 

The following table illustrates the level of concentration as a percentage of net accounts receivable balance as of June 30, 2024 and December 31, 2023. The Top Five Customers category may include federal agency receivable balances if applicable.

 

    June 30, 2024     December 31, 2023  
Top Five Customers     100 %     96 %
Schedule of Computation of Loss Per Share

The following table illustrates our computation of loss per share for the three and six months ended June 30, 2024 and 2023:

  

                 
   

For the Three Months Ended

June 30,

   

For the Six Months Ended

June 30,

 
    2024     2023     2024     2023  
Numerator:                                
Net loss attributable to common shareholders   $ (7,748,534 )   $ (11,114,925 )   $ (16,455,010 )   $ (18,404,566 )
Denominator for basic and diluted loss per share:                                
Weighted average common stock shares outstanding     51,411,779       19,471,057       45,585,472       17,629,225  
Loss per common share - basic and diluted   $ (0.15 )   $ (0.57 )   $ (0.36 )   $ (1.04 )
Schedule of Anti-Dilutive Securities Excluded from Computation of Earnings Per Share

  

             
    As of June 30,  
    2024     2023  
Stock options     14,825,266       3,420,754  
Convertible debt     10,520,985       7,058,298  
Common stock warrants     15,467,354       15,929,601  
Convertible preferred stock:                
Series D Convertible Preferred     6,250       6,250  
Series AA Convertible Preferred     8,645,000       8,601,000  
Series BB Convertible Preferred     28,540,000       3,620,000  
Series CC Convertible Preferred     4,010,000       4,010,000  
Series DD Convertible Preferred     2,540,000       -  
Total potentially dilutive shares      84,554,855       42,645,903  
Summary of Assumptions for the Grants of Stock Options

The following table summarizes the assumptions we utilized for grants of stock options to the three sub-groups of our stock option recipients during the six months ended June 30, 2024:

  

Assumptions   CEO, other Officers and Employees  
Expected life     6.0 (yrs. )
Expected volatility     151.7 %
Risk-free interest rate     4.36 %
Forfeiture rate     0 to 5.00%  
Expected dividend yield     0.0 %
Schedule of Stock Based Compensation Expense

  

                 
    For the Three Months Ended     For the Six Months Ended  
    June 30,     June 30,  
    2024     2023     2024     2023  
Cost of sales   $ 14,965     $ 11,060     $ 29,629     $ 64,541  
Research and development     48,960       35,289       92,217       205,909  
Selling and marketing     (12,790 )     13,426       41,545       85,525  
Consumer Products     (6,188 )     -       19,098       -  
General and administrative     105,081       75,779       207,831       1,209,823  
Total stock-based compensation expense   $ 150,028     $ 135,554     $ 390,320     $ 1,565,798  
Schedule of Assets and Liabilities Measured at Fair Value on Recurring Basis

The following tables set forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of June 30, 2024:

  

         

Fair value measurements at

June 30, 2024 using:

 
   

June 30,

2024

   

Quoted prices in active markets

(Level 1)

   

Significant other

observable inputs

(Level 2)

   

Significant

unobservable inputs

(Level 3)

 
Equity Securities   $ 63,775     $ 63,775       -       -  
Total Financial Assets   $ 63,775     $ 63,775     $ -     $ -  

 

The following tables set forth the Company’s financial assets and liabilities that were accounted for at fair value on a recurring basis as of December 31, 2023:

 

         

Fair value measurements at

December 31, 2023 using:

 
   

December 31,

2023

   

Quoted prices in

active markets

(Level 1)

   

Significant other

observable inputs

(Level 2)

   

Significant

unobservable inputs

(Level 3)

 
Equity Securities     61,876       61,876        -       -  
Total Financial Assets   $ 61,876     $ 61,876     $ -     $ -